Treatment of Liver Tumors with Transarterial Chemoembolization

Natalie Poliektov; D. Thor Johnson

doi:10.1055/s-0038-1673423

Seminars in Interventional Radiology, Table of Contents

Semin intervent Radiol 2018; 35(04): 350-355
DOI: 10.1055/s-0038-1673423

Trainee Corner

Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Treatment of Liver Tumors with Transarterial Chemoembolization

Natalie Poliektov

¹Department of Radiology, University of Colorado College of Medicine, Aurora, Colorado

,

D. Thor Johnson

¹Department of Radiology, University of Colorado College of Medicine, Aurora, Colorado

› Author Affiliations

Abstract

Full Text

References

References
1 Ferlay J, Soerjomataram I, Dikshit R. , et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2015; 136 (05) E359-E386
2 Ryerson AB, Eheman CR, Altekruse SF. , et al. Annual Report to the Nation on the Status of Cancer, 1975-2012, featuring the increasing incidence of liver cancer. Cancer 2016; 122 (09) 1312-1337
3 Marin JJG, Castano B, Martinez-Becerra P. , et al. Chemotherapy in the treatment of primary liver tumours. Cancer Ther 2008; 6: 711-728
4 Doyon D, Mouzon A, Jourde AM, Regensberg C, Frileux C. [Hepatic, arterial embolization in patients with malignant liver tumours (author's transl)]. Ann Radiol (Paris) 1974; 17 (06) 593-603
5 Nakakuma K, Tashiro S, Hiraoka T. , et al. Studies on anticancer treatment with an oily anticancer drug injected into the ligated feeding hepatic artery for liver cancer. Cancer 1983; 52 (12) 2193-2200
6 Bruix J, Sherman M. ; American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma: an update. Hepatology 2011; 53 (03) 1020-1022
7 European Association for the Study of the Liver; European Organisation for Research and Treatment of Cancer. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol 2012; 56 (04) 908-943
8 Rammohan A, Sathyanesan J, Ramaswami S. , et al. Embolization of liver tumors: past, present and future. World J Radiol 2012; 4 (09) 405-412
9 Shin SW. The current practice of transarterial chemoembolization for the treatment of hepatocellular carcinoma. Korean J Radiol 2009; 10 (05) 425-434
10 Garwood ER, Fidelman N, Hoch SE, Kerlan Jr RK, Yao FY. Morbidity and mortality following transarterial liver chemoembolization in patients with hepatocellular carcinoma and synthetic hepatic dysfunction. Liver Transpl 2013; 19 (02) 164-173
11 Osuga K, Maeda N, Higashihara H. , et al. Current status of embolic agents for liver tumor embolization. Int J Clin Oncol 2012; 17 (04) 306-315
12 Speakman TJ. Internal occlusion of a carotid-cavernous fistula. J Neurosurg 1964; 21: 303-305
13 Tadavarthy SM, Moller JH, Amplatz K. Polyvinyl alcohol (Ivalon)--a new embolic material. Am J Roentgenol Radium Ther Nucl Med 1975; 125 (03) 609-616
14 Miyayama S, Matsui O, Yamashiro M. , et al. Ultraselective transcatheter arterial chemoembolization with a 2-f tip microcatheter for small hepatocellular carcinomas: relationship between local tumor recurrence and visualization of the portal vein with iodized oil. J Vasc Interv Radiol 2007; 18 (03) 365-376
15 Nakamura H, Hashimoto T, Oi H, Sawada S. Transcatheter oily chemoembolization of hepatocellular carcinoma. Radiology 1989; 170 (3, Pt 1): 783-786
16 Lencioni R, Petruzzi P, Crocetti L. Chemoembolization of hepatocellular carcinoma. Semin Intervent Radiol 2013; 30 (01) 3-11
17 Takayasu K. Transarterial chemoembolization for hepatocellular carcinoma over three decades: current progress and perspective. Jpn J Clin Oncol 2012; 42 (04) 247-255
18 Marelli L, Stigliano R, Triantos C. , et al. Transarterial therapy for hepatocellular carcinoma: which technique is more effective? A systematic review of cohort and randomized studies. Cardiovasc Intervent Radiol 2007; 30 (01) 6-25
19 Breedis C, Young G. The blood supply of neoplasms in the liver. Am J Pathol 1954; 30 (05) 969-977